Cargando…
Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells
BACKGROUND: Resistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression. C35 is over-expressed in many invasive breast cancer endogenously, and functions as an oncogene in breast cancer cell lines. METHODS: Th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578656/ https://www.ncbi.nlm.nih.gov/pubmed/28859163 http://dx.doi.org/10.1371/journal.pone.0183941 |